U.S. Physical Therapy, Inc.

NYSE:USPH

91.31 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994199319921991
Revenue 604.802553.144495.022422.969481.969453.911414.051356.546331.302305.074264.058252.088237.006211.233201.409187.686151.686135.194132.122118.308105.56894.73980.94863.22249.9354438.832.224.917.28.42.40.6
Cost of Revenue 492.816441.12377.84328.519369.495352.248323.434274.534252.941228.907199.357189.503172.513151.816146.239140.083114.32599.35196.2185.27574.60464.53154.8842.934.09230.827.322.117.413.26.21.70.5
Gross Profit 111.986112.024117.18294.45112.474101.66390.61782.01278.36176.16764.70162.58564.49359.41755.1747.60337.36135.84335.91233.03330.96430.20826.06820.32215.84313.211.510.17.542.20.70.1
Gross Profit Ratio 0.1850.2030.2370.2230.2330.2240.2190.230.2370.250.2450.2480.2720.2810.2740.2540.2460.2650.2720.2790.2930.3190.3220.3210.3170.30.2960.3140.3010.2330.2620.2920.167
Reseach & Development Expenses 000000000000000000000000000000000
General & Administrative Expenses 51.95346.11146.53342.03745.04941.34935.88932.47931.06730.39925.93124.78224.77722.98623.39523.72717.32617.24716.42516.80213.96711.3349.127.6076.4875.64.84.800000
Selling & Marketing Expenses -9.52300000000000000000000000000000000
SG&A 42.4346.11146.53342.03745.04941.34935.88932.47931.06730.39925.93124.78224.77722.98623.39523.72717.32617.24716.42516.80213.96711.3349.127.6076.4875.64.84.84.24.53.51.70.4
Other Expenses 00.859-4.597-13.501000000003.7853.2413.3480000.6040.2380002.3312.092.11.91.71.71.30.60.20
Operating Expenses 42.4346.11141.93628.53645.04941.34935.88932.47931.06730.39925.93124.78228.56226.22726.74323.72717.32617.24717.02917.0413.96711.3349.129.9388.5777.76.76.55.95.84.11.90.4
Operating Income 69.55656.80176.77352.41367.42560.31454.72849.53347.29445.76838.7737.80335.93133.1928.42723.87620.03518.59618.88315.99316.99718.87416.94810.3847.2665.54.83.61.6-1.8-1.9-1.2-0.3
Operating Income Ratio 0.1150.1030.1550.1240.140.1330.1320.1390.1430.150.1470.150.1520.1570.1410.1270.1320.1380.1430.1350.1610.1990.2090.1640.1460.1250.1240.1120.064-0.105-0.226-0.5-0.5
Total Other Income Expenses Net -20.18-1.232.54713.13.481-0.103-20.972-11.385-7.158-1.07-0.5310.0520.4460.35-0.344-0.282-5.755-5.346-5.612-0.366-5.159-5.064-5.445-4.246-3.304-2.8-2.3-1.90.30000.3
Income Before Tax 49.37655.57173.19665.51370.90660.21133.75638.14846.34444.69838.23937.25240.8833.5428.08316.50914.2813.2514.30210.77711.78313.72411.5036.1383.9622.72.51.71.90000
Income Before Tax Ratio 0.0820.10.1480.1550.1470.1330.0820.1070.140.1470.1450.1480.1720.1590.1390.0880.0940.0980.1080.0910.1120.1450.1420.0970.0790.0610.0640.0530.0760000
Income Tax Expense 12.15612.16415.27213.02213.64711.3696.03211.8814.65314.27412.23611.03411.0978.848.1096.5055.4655.0575.5114.0994.4525.2364.4322.4031.5681.10.10.10.910.300.2
Net Income 14.67443.40757.92452.49157.25910.10322.25620.55122.27919.76712.72317.93320.97415.64511.76710.0048.8926.2968.7916.6787.3318.4887.0713.7352.3941.62.41.60.7-2.8-2.2-1.2-0.2
Net Income Ratio 0.0240.0780.1170.1240.1190.0220.0540.0580.0670.0650.0480.0710.0880.0740.0580.0530.0590.0470.0670.0560.0690.090.0870.0590.0480.0360.0620.050.028-0.163-0.262-0.5-0.333
EPS 1.283.344.494.094.490.81.761.641.771.621.051.521.781.341.010.840.750.540.740.560.660.770.70.130.120.050.0760.0510.022-0.27-0.22-0.12-0.025
EPS Diluted 1.283.344.494.094.490.81.761.641.771.621.051.511.751.3210.830.750.540.730.540.610.670.550.110.110.0470.0730.0510.022-0.27-0.22-0.12-0.025
EBITDA 74.37476.09385.72977.6883.0872.00864.52658.40555.32752.52644.33943.09646.82539.44334.15730.10225.02123.0924.83520.82720.58821.82919.51412.7159.3567.66.75.33.3-0.5-1.3-1-0.3
EBITDA Ratio 0.1230.1490.1790.1810.1720.1550.1560.1640.1670.1720.1680.1710.1980.1870.170.1590.1650.1710.180.1740.1950.230.2410.2010.1870.1770.1730.1650.12-0.029-0.155-0.417-0.5